Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Nov 12, 2020 3:50 PM - Nov 12, 2020 6:00 PM

(Central Europe Standard Time)

4051 Basel, Switzerland

Workshop: Best Practices for the Redaction and Anonymization of Clinical Documents (separate registration required)

Instructors

Scott  Feiner

Scott Feiner

Senior Manager, Trial Disclosure, AbbVie, United States

Scott has over a decade of experience with clinical trial disclosure, initially working for smaller sponsors as a one-person clinical trial disclosure department, to later operating in larger organizations, serving as an expert in summary results reporting and clinical document redaction/anonymization for public disclosure. As part of implementation planning for the EU Clinical Trials Regulation, Scott is AbbVie’s representative in the EMA CTIS sponsor master trainer programme.

Lora  Killian, MBA

Lora Killian, MBA

Clinical Trial Transparency and Disclosure Lead, Pfizer, United States

Lora has 20+ years of business experience, including more than a decade of pharmaceutical industry experience. She started her career in the military serving four years of active duty in the Medical Service Corp for the U.S. Army. In her first pharmaceutical industry position, Lora served for 4 years as Director of Operations for a small medical writing company. She transitioned to Transparency and Disclosure in 2014. During her 8 years in Transparency and Disclosure, Lora has overseen delivery of 5500+ redacted and anonymized documents to support European Medicines Agency Policy 0070, Health Canada Public Release of Clinical Information, other global disclosure regulations and broader corporate transparency policies for many sponsors.

Lukasz  Kniola

Lukasz Kniola

Principal Analyst, Data Sharing, Biogen, United Kingdom

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.